Ariel Monet Leyte-Vidal

2PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 16, 2025
How I individualize frontline treatment for chronic-phase CML.

Ariel Leyte-Vidal, Neil P Shah

|Apr 21, 2024
BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib.

Ariel Leyte-Vidal, Diego Garrido Ruiz, RosaAnna DeFilippis

Pageof 1